|
1
|
Marqués-Lespier JM1, González-Pons M and
Cruz-Correa M: Current perspectives on gastric cancer.
Gastroenterol Clin North Am. 45:413–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhong J, Chen Y and Wang LJ: Emerging
molecular basis of hematogenous metastasis in gastric cancer. World
J Gastroenterol. 22:2434–2440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan H, Yuan J, Gao L, Rao J and Hu J: Long
noncoding RNA MEG3 activation of p53 mediates ischemic neuronal
death in stroke. Neuroscience. 337:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu X, Hou L, Huang W, Gao Y, Lv X and
Tang J: The mechanism of long non-coding RNA MEG3 for neurons
apoptosis caused by hypoxia: Mediated by miR-181b-12/15-LOX
signaling pathway. Front Cell Neurosci. 10:2012016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kam Y, Rubinstein A, Naik S, Djavsarov I,
Halle D, Ariel I, Gure AO, Stojadinovic A, Pan H, Tsivin V, et al:
Detection of a long non-coding RNA (CCAT1) in living cells and
human adenocarcinoma of colon tissues using FIT-PNA molecular
beacons. Cancer Lett. 352:90–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Avilion AA, Nicolis SK, Pevny LH, Perez L,
Vivian N and Lovell-Badge R: Multipotent cell lineages in early
mouse development depend on SOX2 function. Genes Dev. 17:126–140.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fong H, Hohenstein KA and Donovan PJ:
Regulation of self-renewal and pluripotency by Sox2 in human
embryonic stem cells. Stem Cells. 26:1931–1938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shahryari A, Jazi MS, Samaei NM and Mowla
SJ: Long non-coding RNA SOX2OT: Expression signature, splicing
patterns, and emerging roles in pluripotency and tumorigenesis.
Front Genet. 6:1962015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu S, Xu B and Yan D: Enhanced expression
of long non-coding RNA Sox2ot promoted cell proliferation and
motility in colorectal cancer. Minerva Med. 107:279–286.
2016.PubMed/NCBI
|
|
12
|
Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu
C, Chang C, Bi H, Zou J, Yao X, et al: A long noncoding RNA Sox2ot
regulates lung cancer cell proliferation and is a prognostic
indicator of poor survival. Int J Biochem Cell Biol. 53:380–388.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Yang R, Lian J and Xu H: LncRNA
Sox2ot overexpression serves as a poor prognostic biomarker in
gastric cancer. Am J Transl Res. 8:5035–5043. 2016.PubMed/NCBI
|
|
14
|
Meister G: miRNAs get an early start on
translational silencing. Cell. 131:25–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D
and Quan ZW: Long noncoding RNA H19 contributes to gallbladder
cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Tumour Biol. 37:9721–9730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J,
Chen J, Liu L, Cai H, Li Z, et al: Knockdown of SOX2OT inhibits the
malignant biological behaviors of glioblastoma stem cells via
up-regulating the expression of miR-194-5p and miR-122. Mol Cancer.
16:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi XM and Teng F: Up-regulation of long
non-coding RNA Sox2ot promotes hepatocellular carcinoma cell
metastasis and correlates with poor prognosis. Int J Clin Exp
Pathol. 8:4008–4014. 2015.PubMed/NCBI
|
|
19
|
Huber MA, Beug H and Wirth T:
Epithelial-mesenchymal transition: NF-kappaB takes center stage.
Cell Cycle. 3:1477–1480. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: Trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou X, Yuan P, Liu Q and Liu Z: LncRNA
MEG3 regulates imatinib resistance in chronic myeloid leukemia via
suppressing MicroRNA-21. Biomol Ther (Seoul). 25:490–496. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Lei B, Wu H, Zhang X and Zheng N:
Tumor suppressive role of miR-194-5p in glioblastoma multiforme.
Mol Med Rep. 16:9317–9322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Wei T, Shim K, Wright K, Xu K,
Palka-Hamblin HL, Jurkevich A and Khare S: Atypical role of sprouty
in colorectal cancer: Sprouty repression inhibits
epithelial-mesenchymal transition. Oncogene. 35:3151–3162. 2016.
View Article : Google Scholar : PubMed/NCBI
|
